Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weidong Han

Showing results (381-390 of 393) with videos related to

Pageof 40
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 25, 2022
Identification of a STIM1 Splicing Variant that Promotes Glioblastoma GrowthJiansheng Xie, Guolin Ma, Lijuan Zhou, et al.
Journal of Hematology & Oncology|November 27, 2016
Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemiaBo Cai, Mei Guo, Yao Wang, et al.
Theranostics|March 23, 2021
Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphomaQingzhu Jia, Diyuan Qin, Feng He, et al.
Chinese Medical Journal|August 19, 2022
Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathyHeng Mei, Fangping Chen, Yue Han, et al.
Chinese Medical Journal|November 5, 2024
Recommendations for the timing, dosage, and usage of corticosteroids during cytokine release syndrome (CRS) caused by chimeric antigen receptor (CAR)-T cell therapy for hematologic malignanciesSanfang Tu, Xiu Luo, Heng Mei, et al.
Stem Cell Research & Therapy|May 3, 2022
Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trialLi Zang, Yijun Li, Haojie Hao, et al.
Cell|August 22, 2025
Glycan shielding enables TCR-sufficient allogeneic CAR-T therapyZeguang Wu, Jinhong Shi, Qiezhong Lamao, et al.
Nature Cancer|February 27, 2024
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunityHaojie Dong, Xin He, Lei Zhang, et al.
Human Molecular Genetics|October 30, 2023
A large-scale microRNA transcriptome-wide association study identifies two susceptibility microRNAs, miR-1307-5p and miR-192-3p, for colorectal cancer riskZhishan Chen, Weiqiang Lin, Qiuyin Cai, et al.
Cancer Biology & Medicine|March 2, 2023
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphomaPing Li, Yang Liu, Yun Liang, et al.
Pageof 40

Showing results (381-390 of 393) with videos related to

Sort By:
Pageof 40
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 25, 2022
Identification of a STIM1 Splicing Variant that Promotes Glioblastoma GrowthJiansheng Xie, Guolin Ma, Lijuan Zhou, et al.
Journal of Hematology & Oncology|November 27, 2016
Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemiaBo Cai, Mei Guo, Yao Wang, et al.
Theranostics|March 23, 2021
Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphomaQingzhu Jia, Diyuan Qin, Feng He, et al.
Chinese Medical Journal|August 19, 2022
Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathyHeng Mei, Fangping Chen, Yue Han, et al.
Chinese Medical Journal|November 5, 2024
Recommendations for the timing, dosage, and usage of corticosteroids during cytokine release syndrome (CRS) caused by chimeric antigen receptor (CAR)-T cell therapy for hematologic malignanciesSanfang Tu, Xiu Luo, Heng Mei, et al.
Stem Cell Research & Therapy|May 3, 2022
Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trialLi Zang, Yijun Li, Haojie Hao, et al.
Cell|August 22, 2025
Glycan shielding enables TCR-sufficient allogeneic CAR-T therapyZeguang Wu, Jinhong Shi, Qiezhong Lamao, et al.
Nature Cancer|February 27, 2024
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunityHaojie Dong, Xin He, Lei Zhang, et al.
Human Molecular Genetics|October 30, 2023
A large-scale microRNA transcriptome-wide association study identifies two susceptibility microRNAs, miR-1307-5p and miR-192-3p, for colorectal cancer riskZhishan Chen, Weiqiang Lin, Qiuyin Cai, et al.
Cancer Biology & Medicine|March 2, 2023
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphomaPing Li, Yang Liu, Yun Liang, et al.
Pageof 40